Keyword: Pharmstandard to spin off over the counter business
News
15.08.2013
- Russian drugmaker Pharmstandard has agreed to buy a supplier of ingredients for its flagship anti-viral and anxiety drugs for $590 million, as part of a plan to spin off its over...